These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22857525)

  • 1. Development of continuous pharmaceutical production processes supported by process systems engineering methods and tools.
    Gernaey KV; Cervera-Padrell AE; Woodley JM
    Future Med Chem; 2012 Jul; 4(11):1371-4. PubMed ID: 22857525
    [No Abstract]   [Full Text] [Related]  

  • 2. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples.
    Ooi SM; Sarkar S; van Varenbergh G; Schoeters K; Heng PW
    Ther Deliv; 2013 Apr; 4(4):463-70. PubMed ID: 23557287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
    Scott B; Wilcock A
    PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 8. Greener pharmaceuticals.
    Clark JH; Breeden SW; Summerton L
    Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
    [No Abstract]   [Full Text] [Related]  

  • 9. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 10. Advancing in the face of conventional wisdom.
    Lanzara R
    Drug Discov Today; 2004 Feb; 9(3):110-1. PubMed ID: 14960386
    [No Abstract]   [Full Text] [Related]  

  • 11. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 12. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 14. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the development of chiral drugs.
    Caner H; Groner E; Levy L; Agranat I
    Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394
    [No Abstract]   [Full Text] [Related]  

  • 16. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs.
    Wolfson W
    Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292
    [No Abstract]   [Full Text] [Related]  

  • 17. Future directions of imaging MS in pharmaceutical R&D.
    Goodwin RJ; Webborn PJ
    Bioanalysis; 2015; 7(20):2667-73. PubMed ID: 26510897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big interest in heavy drugs.
    Sanderson K
    Nature; 2009 Mar; 458(7236):269. PubMed ID: 19295573
    [No Abstract]   [Full Text] [Related]  

  • 19. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
    Karanth H; Shenoy VS; Murthy RR
    AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical drug development].
    Castro B
    Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.